异基因造血细胞移植后进展性慢性淋巴细胞白血病。
Progressive chronic lymphocytic leukemia after allogeneic hematopoietic cell transplantation.
机构信息
Department of Medicine, BMT Program, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
出版信息
J Natl Compr Canc Netw. 2012 Oct 1;10(10):1203-6. doi: 10.6004/jnccn.2012.0127.
PMID:23054874
Abstract
This case report presents a patient with poor-prognosis chronic lymphocytic leukemia (CLL) who was treated with chemotherapy and underwent allogeneic hematopoietic cell transplant (alloHCT) but ultimately progressed. The application of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for CLL and the impact of alloHCT on secondary therapy for progressive CLL are discussed.
摘要
本病例报告介绍了一位预后不良的慢性淋巴细胞白血病（CLL）患者，该患者接受了化疗和异基因造血细胞移植（alloHCT）治疗，但最终进展。讨论了 NCCN 临床实践指南在肿瘤学（NCCN 指南）中的应用以及 alloHCT 对进展性 CLL 二线治疗的影响。
Zotero 插件